A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that
Synthetic biology represents a revolutionary discipline that applies engineering principles to biology, aiming to develop cells into sophisticated micro-factories capable of producing essential materials. With the potential to spearhead advancements across numerous industries—including medicine,
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell
Switzerland has established itself as a global leader in the biotech industry, making significant advancements in areas such as cancer treatment, immunotherapy, gene and cell therapy, and more. With a strong focus on personalized and precision medicine, the Swiss biotech sector thrives on
Synthetic biology, commonly known as synbio, is at the cutting edge of biotechnology, offering revolutionary solutions for various industries. Dr. John Cumbers, a pioneering figure in this field and the Founder and CEO of SynBioBeta LLC, provides profound insights into how synbio can address